3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
7
Recurrence
1
Pheochromocytoma
1
Paraganglioma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors
1
Neoplasms
1
Interventions
Vorinostat
1
Temozolomide
1
Interleukin-12
1
Aminolevulinic Acid
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neuroectodermal Tumors
×
3-Iodobenzylguanidine
×
Clear all
NCT03561259
2023-02-16
OPTIMUM
Jubilant DraxImage Inc.
Phase 2
Unknown
60 enrolled